COEUS appoints Daniel Garrett as independent board member.
September 14, 2021 – Devon, PA – COEUS, formerly COEUS Holdings, a leading healthcare communications, technology, talent, and consulting firm delivering a variety of services and platforms to all stakeholders in the healthcare ecosystem, today announced it has appointed Daniel Garrett to its board as an independent director. Mr. Garrett joins the COEUS board after a successful career in healthcare as PwC’s Technology Consulting Leader for PwC US & Trifecta (US, China/HK, and Japan). Dan also serves on the Board of Directors of the eHealth Initiative as a leader driving healthcare transformation, convening leaders from across the healthcare industry.
At PwC, Dan had cross-industry responsibility of refining and executing strategy and overseeing all of PwC’s Technology Consulting Functions. In addition, Dan served as the US leader of the Health Industries IT (HIT) practice and was their global Health Industries Analytics Lead, with responsibility for coordinating the practice across the PwC network. In that capacity Dan lead all analytics, digital, and cyber security initiatives, as well as Tech Consulting efforts. The HIT practice has been ranked by multiple industry analysts as a leading HIT consulting firm, with the greatest depth and breadth of expertise. He came to PwC from CSC, where he was the EVP and Managing Partner leading CSC’s healthcare practice.
“Dan’s proven leadership at the board level will be a tremendous asset to the organization as we continue to scale and build the COEUS family of companies into a world class organization,” said Marc Hixson, CEO of COEUS. “In addition, his experience in healthcare technology will be instrumental as we continue to grow our client base and offerings around COEUS HealthCare’s recently launched COEBRA platform focused on supporting the healthcare industry’s movement towards value by demonstrating the clinical and cost effectiveness of life-saving products, as well as our technology offerings being built and implemented by COEUS Solutions.”
“I am truly pleased to be joining the COEUS board during a time of exponential growth within the organization and look forward to contributing my knowledge and experience to the organization,” said Mr. Garrett, “the team that COEUS has been able to assemble to date is second to none and combined with the technology solutions the company has/are developing will ensure they are a market leader in ensuring patients have access to appropriate therapies when needed.
Established in 2009, COEUS is a leading healthcare consulting, communications, technology, and talent firm. The company offers clients a variety of services, as well as SaaS technology platforms, for various stakeholders throughout the healthcare ecosystem including all payers and emerging or more established drug manufacturers. Leveraging the deep knowledge and experience of the company’s many subject matter experts, COEUS works on all drug types with a particular focus on cell and gene therapies, rare diseases, and oncology. The company also has unique expertise in the creation and management of value-based agreements by leveraging COEBRA™, the company’s evidence and outcomes adjudication platform. In its 13-year history, the company has supported the launch of more than 120 pharmaceutical brands and has worked with more than 300 pharma clients including many top global pharmaceutical manufacturers. To learn more about COEUS and the company’s offerings, visit 1coeus.com.
COEUS Media Contact:
Owen Murphy | 215.680.0155